Dicerna Announces Full Year 2020 Financial Results and Provides a Business Update
LEXINGTON, Mass.--(BUSINESS WIRE)--Feb 25, 2021-- Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of investigational ribonucleic...
